EUVIMEDEUVIMED entdecken
Korrektur

Correction to “Treatment‐Specific Clinical and Urinary Biomarker Signatures Associated With Response to Intravesical Botulinum Toxin A and Platelet‐Rich Plasma in Bladder Pain Syndrome”

LUTS: Lower Urinary Tract Symptoms · 2026-07 · 18 (4)

DOI: 10.1111/luts.70070 ↗

Kurz gefasst

Korrektur in der Zeitschrift LUTS: Lower Urinary Tract Symptoms, online erschienen am 02.06.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Correction to “Treatment‐Specific Clinical and Urinary Biomarker Signatures Associated With Response to Intravesical Botulinum Toxin A and Platelet‐Rich Plasma in Bladder Pain Syndrome”. LUTS: Lower Urinary Tract Symptoms, 18(4). https://doi.org/10.1111/luts.70070

Vancouver

Correction to “Treatment‐Specific Clinical and Urinary Biomarker Signatures Associated With Response to Intravesical Botulinum Toxin A and Platelet‐Rich Plasma in Bladder Pain Syndrome”. LUTS: Lower Urinary Tract Symptoms. 2026;18(4). doi:10.1111/luts.70070

BibTeX
@article{euvimed2026,
  title = {Correction to “Treatment‐Specific Clinical and Urinary Biomarker Signatures Associated With Response to Intravesical Botulinum Toxin A and Platelet‐Rich Plasma in Bladder Pain Syndrome”},
  journal = {LUTS: Lower Urinary Tract Symptoms},
  year = {2026},
  volume = {18},
  number = {4},
  doi = {10.1111/luts.70070}
}
Kostenlos starten →